ProfileGDS4718 / 1556639_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 16% 21% 29% 17% 14% 23% 28% 14% 17% 16% 9% 15% 20% 20% 16% 21% 27% 22% 18% 23% 19% 13% 14% 25% 21% 17% 23% 15% 21% 18% 22% 25% 9% 10% 25% 20% 22% 22% 23% 23% 18% 19% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0710218
GSM549102patient 115, normal, homogenized [OPG study]4.0043716
GSM549104patient 119, normal, homogenized [OPG study]4.1706521
GSM549108patient 138, normal, homogenized [OPG study]4.5237929
GSM549119patient 077, normal, homogenized [OPG study]4.0270717
GSM549133patient 032, cancer, homogenized [OPG study]3.8831914
GSM549139patient 042, cancer, homogenized [OPG study]4.2469123
GSM549099patient 107, normal, homogenized [OPG study]4.4922328
GSM549109patient 139, normal, homogenized [OPG study]3.9578214
GSM549110patient 046, normal, homogenized [OPG study]4.0436417
GSM549114patient 063, normal, homogenized [OPG study]3.9795616
GSM549122patient 082, normal, homogenized [OPG study]3.746849
GSM549134patient 033, cancer, homogenized [OPG study]3.968915
GSM549136patient 036, cancer, homogenized [OPG study]4.0929220
GSM549140patient 044, cancer, homogenized [OPG study]4.0972720
GSM549111patient 047, normal, homogenized [OPG study]3.9901916
GSM549113patient 057, normal, homogenized [OPG study]4.1323721
GSM549132patient 031, cancer, homogenized [OPG study]4.3983527
GSM549137patient 038, cancer, homogenized [OPG study]4.2054422
GSM549142patient 047, cancer, homogenized [OPG study]4.174118
GSM549100patient 110, normal, homogenized [OPG study]4.2868923
GSM549107patient 135, normal, homogenized [OPG study]4.0866719
GSM549115patient 068, normal, homogenized [OPG study]3.8498413
GSM549116patient 072, normal, homogenized [OPG study]3.9238514
GSM549120patient 078, normal, homogenized [OPG study]4.3512125
GSM549131patient 030, cancer, homogenized [OPG study]4.1508321
GSM549118patient 074, normal, homogenized [OPG study]4.0463717
GSM549129patient 027, cancer, homogenized [OPG study]4.2914623
GSM549123patient 088, normal, homogenized [OPG study]3.9468915
GSM549124patient 006, cancer, homogenized [OPG study]4.2065621
GSM549126patient 015, cancer, homogenized [OPG study]4.0473718
GSM549128patient 025, cancer, homogenized [OPG study]4.1798622
GSM549103patient 117, normal, homogenized [OPG study]4.3935825
GSM549117patient 073, normal, homogenized [OPG study]3.739699
GSM549138patient 041, cancer, homogenized [OPG study]3.7627610
GSM549141patient 045, cancer, homogenized [OPG study]4.2975425
GSM549130patient 028, cancer, homogenized [OPG study]4.1426820
GSM549101patient 111, normal, homogenized [OPG study]4.2353422
GSM549105patient 128, normal, homogenized [OPG study]4.2480222
GSM549106patient 134, normal, homogenized [OPG study]4.1989223
GSM549112patient 048, normal, homogenized [OPG study]4.2432423
GSM549125patient 011, cancer, homogenized [OPG study]4.0648818
GSM549127patient 024, cancer, homogenized [OPG study]4.0768719
GSM549135patient 035, cancer, homogenized [OPG study]3.982317